Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 2—February 2024
Dispatch

Using Insurance Claims Data to Estimate Blastomycosis Incidence, Vermont, USA, 2011–2020

Brian F. BorahComments to Author , Paul Meddaugh, Veronica Fialkowski, and Natalie Kwit
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (B. Borah); Vermont Department of Health, Burlington, Vermont, USA (B. Borah, P. Meddaugh, N. Kwit); Green Mountain Care Board, Montpelier, Vermont, USA (V. Fialkowski)

Main Article

Figure 1

Numbers of patients with blastomycosis, attributable deaths per year, and annual incidence (cases/100,000 population) in Vermont, USA, 2011–2020. Results are suppressed for years with ≤10 patients, in accordance with the Green Mountain Care Board data use agreement for the Vermont Health Care Uniform Reporting and Evaluation System.

Figure 1. Numbers of patients with blastomycosis, attributable deaths per year, and annual incidence (cases/100,000 population) in Vermont, USA, 2011–2020. Results are suppressed for years with ≤10 patients, in accordance with the Green Mountain Care Board data use agreement for the Vermont Health Care Uniform Reporting and Evaluation System.

Main Article

Page created: December 21, 2023
Page updated: January 24, 2024
Page reviewed: January 24, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external